Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman
6/26/2013 6:26:13 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
OXFORD, England, June 26, 2013 /PRNewswire/ --
Oxford BioTherapeutics (OBT), a global biotechnology company developing first-in-class, antibody-based cancer medicines to fulfil unmet patient needs, today announces the appointment of Bryan G. Morton as the Company's new Non-executive Chairman.
Help employers find you! Check out all the jobs and post your resume.